Autoimmune Diseases  >>  Rinvoq (upadacitinib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rinvoq (upadacitinib) / AbbVie
NCT01741493: A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494

Completed
1
67
US
ABT-494, Placebo, Tofacitinib
AbbVie (prior sponsor, Abbott)
Rheumatoid Arthritis
12/13
12/13

Download Options